The manufacturer received information alleging an issue related to a continuous positive airway pressure (cpap) device's sound abatement foam.The patient alleges seizure, shortness of breath, and tongue swelling.Patient also alleges that the device has a strange odor.Medical intervention was not specified.This issue was reported to the fda per 21 cfr 806.The device will be corrected per res 88058.
|
The manufacturer previously reported information in reference to the voluntary field safety notice / recall notification related to the sound abatement foam in certain cpap, bipap, and mechanical ventilator devices.The patient alleged seizure, shortness of breath, losing weight, and tongue swelling.Patient also alleges that the device has a strange odor.Additional information has been received after review from a clinical expert that the allegation of seizures and losing weight was assessed as not related to the device and therefore is not a reportable injury.There is no allegation of serious or permanent harm or injury.No medical intervention was required by the patient.This report is being filed as a correction to the original report and is no longer an adverse event.This is being filed as a product problem only.The previous report was also filed as an initial/final, however the manufacturer's investigation is now ongoing.A follow-up report will be submitted when the manufacturer's investigation is complete.The updated coding in h6 reflects this change.
|